Skip to Main Content

Paper Details

Integrated Human and Murine Clinical Study Establishes Clinical Efficacy of Ruxolitinib in Chronic Myelomonocytic Leukemia.
Clin Cancer Res
11
2021
Author NameAffiliation
David P SteensmaDana-Farber Cancer Institute
Markus BallH. Lee Moffitt Cancer Center
  • 1 - 2

Datasets

Release 1.2